IntelvsNutex Health

INTC and NUTX stock compared: price, dividend, valuation and results, from SEC filings.

INTC

Intel Corporation

$59.66

Value $317B

-2.52%
INTC's page

NUTX

Nutex Health Inc.

$173.67

Value $1.2B

+1.32%
NUTX's page

Intel (INTC) has a market value of $317B and Nutex Health (NUTX) $1.2B. Over the last year, with dividends, INTC moved +57.5% and NUTX +42.8%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INTC$317B

    NUTX$1.2B

    INTC is 262 times NUTX

  • Revenue, 12 months

    INTC$59.9B

    NUTX$797M

    INTC is 75 times NUTX

  • Net income, 12 months

    INTC-$12.0B

    NUTX$165M

  • Operating margin

    INTC2.9%

    NUTX39.0%

    36.1 points apart

  • ROIC

    INTC0.9%

    NUTX61.1%

    60.2 points apart

  • P/E

    INTC–

    NUTX7.4

  • Dividend yield

    INTC0.0%

    NUTX0.0%

    About the same

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INTC+58.2%

NUTX+358.7%

0200400600202420252026
Returns by period
PeriodINTCWith dividendsNUTXWith dividends
1 year since November 12, 2025+57.5%Price +57.5%+42.8%Price +42.8%
3 years since November 13, 2023+58.2%+16.5% a yearPrice +56.1%+361.3%+66.5% a yearPrice +361.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INTCIntelNUTXNutex Health

Valuation

INTCNUTX
Valuation
Price$59.66$173.67
Market value$317B$1.2B
Enterprise value (EV)$313B$1.3B
P/E–7.4
P/E, 5-year median––
P/B2.82.8
EV/EBIT177.84.2
Free cash flow yield1.2%20.5%

Results and growth

INTCNUTX
Results and growth
Revenue, 12 months$59.9B$797M
Net income, 12 months-$12.0B$165M
Free cash flow, 12 months$3.8B$248M
Earnings per share, 12 months-$2.42$23.22
Revenue growth, year on year-0.5%82.4%
Revenue growth a year, past-7.5%over 5 years+26.1%over 5 years
EPS growth a year, past–-17.2%over 5 years

Margins and returns on capital

INTCNUTX
Margins and returns on capital
Gross margin39.9%47.8%
Operating margin2.9%39.0%
Net margin-20.1%20.7%
ROIC0.9%61.1%
ROE-11.3%45.2%

Balance sheet

INTCNUTX
Balance sheet
Cash$54.0B$250M
Total debt$50.1B$365M
Net debt / EBITDA-0.30.3
Interest cover1.5×16.2×

Dividends and buybacks

INTCNUTX
Dividends and buybacks
Dividend yield––
Dividend per share, 12 months––
Dividend growth a year, past––
Buyback yield–0.4%
Shareholder yield–0.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INTC or NUTX

Didn't find what you were looking for?

Ask us
Which is bigger, Intel or Nutex Health?

By market value, Intel ($317B) is about 262.0 times Nutex Health ($1.2B), at today's prices.

How did INTC and NUTX stock do over the last 3 years?

Since November 13, 2023, INTC's price moved +56.1% and NUTX's +361.3%. With dividends: INTC +58.2% (+16.5% a year), NUTX +361.3% (+66.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, INTC or NUTX?

Neither paid a dividend over the last twelve months: Intel and Nutex Health return money to shareholders, if they do, in other ways, such as buybacks.

Which has the higher profit margins, Intel or Nutex Health?

Over the last twelve months, the net margin was -20.1% for Intel and 20.7% for Nutex Health, and the operating margin 2.9% and 39.0%. Revenue was $59.9B and $797M.

Which is the better investment, Intel or Nutex Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.